Abingdon Health Plc
ABDXFOTCHealthcare● Active
$0.17
+$0.00(+0.00%)
Market Cap$32218912
P/E Ratio—
52W High$0.209
52W Low$0.07
Abingdon Health Plc (ABDXF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ABDXF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 17, 2026EPS Actual
-$0.01
Revenue
$0.01B
Est. $0.01B · -5.8%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 17, 2026
After Market Close
▼ Miss Revenue
ABDXF reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2026 | Nov 18, 2026 | $0.00 | — | — | — | $0.01B | — |
| — Q1 FY2026 | Mar 17, 2026 | — | -$0.01 | — | $0.01B | $0.01B | -5.8% |
| — Q2 FY2025 | Jun 30, 2025 | — | -$0.00 | — | $0.01B | — | — |
| — Q1 FY2025 | Mar 24, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2024 | Oct 9, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q1 FY2024 | Mar 14, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.01 | — | $0.00B | — | — |
Q4 FY2026
Nov 18, 2026
EPS Actual
—
EPS Est.
$0.00
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 17, 2026
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2025
Jun 30, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2025
Mar 24, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Oct 9, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2024
Mar 14, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 17, 2026 | — | $0.07 | $0.07 | +0.00% |
| — Q2 FY2025 | Jun 30, 2025 | — | $0.07 | $0.07 | +0.00% |
| — Q1 FY2025 | Mar 24, 2025 | — | $0.07 | $0.07 | +0.00% |
| — Q4 FY2024 | Oct 9, 2024 | — | $0.07 | $0.07 | +0.00% |
| — Q1 FY2024 | Mar 14, 2024 | — | $0.07 | $0.07 | +0.00% |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.07 | $0.07 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.07 | $0.07 | +0.00% |
| — Q2 FY2022 | Jun 30, 2022 | — | No price data | $0.07 | — |
Q1 FY2026+0.00%
Report Date
Mar 17, 2026
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q2 FY2025+0.00%
Report Date
Jun 30, 2025
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q1 FY2025+0.00%
Report Date
Mar 24, 2025
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q4 FY2024+0.00%
Report Date
Oct 9, 2024
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q1 FY2024+0.00%
Report Date
Mar 14, 2024
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q2 FY2022—
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
—
Price After
$0.07
Beat Rate0 / 8 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ABDXF ends December
Abingdon Health Plc (ABDXF) most recently reported earnings on March 17, 2026 for Q1 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of —). The next ABDXF earnings date is expected around September 1, 2026.
Each quarter, investors track ABDXF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ABDXF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ABDXF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ABDXF earnings · 4 questionsAbingdon Health Plc's next earnings report is expected around September 1, 2026. ABDXF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ABDXF historically reports after market close (AMC).
ABDXF earnings datewhen is ABDXF earningsABDXF next earnings datewhen does ABDXF report earningsABDXF earnings calendar
▸ Source: FMP · Abingdon Health Plc SEC filings · US GAAP · Abingdon Health Plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026